| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs3738934 |
X-13431--nonanoylcarnitine* |
T/C |
6234 |
0.62 |
-0.106 (0.004) |
1.21·10-134 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs3738934 |
| Chromosomal location | Chr2: 210,582,491 (2q34) |
| Gene (distance) | ACADL (-178,470) |
| Predicted causal gene | ACADL |
| Gene/protein classification | - |
| Metabolite (Pathway) | X-13431--nonanoylcarnitine* (Carnitine metabolism; Lipid) |
| Biochemical locus-metabolite relationship | ACADL encodes Long-chain acyl-CoA dehydrogenase which has activity against a variety of medium and long chain acyl-CoAs [10832093]. X-13431 has been identified as nonaylcarnitine (C9:0) [23093944]. Acyl-CoAs and acyl-carnitines are readily interconverted. |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | C9/C10:2 [20037589]; X-13431 [23093944] |
| Inborn error of metabolism | Long chain acyl-CoA dehydrogenase deficiency |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |